Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Dosing Regimen of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men.

NCT03242590 is registered in ClinicalTrials.gov with Lipocine Inc. as lead sponsor.

NCT NCT03242590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03242590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Dosing Regimen of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men.
Lead sponsor
Lipocine Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2016
Completion date
July 31, 2017
Enrollment
95 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism, male